LATEST ALERTS
The lack of a clear regulatory pathway to market for CBD products in the US is highlighted by a row over the FDA’s denial of new dietary ingredient (NDI) approval for full spectrum hemp extracts
Patience continues to be the watchword when it comes to innovation in the cannabinoid beverage space. Developments continue but companies appear willing to take their time to enter the market as regulation loosens
The USPTO Appeals Board verdict upholding the USPTO’s decision to not grant Joy Tea a trademark covering CBD beverages should come as no surprise
Discount supermarket chain Lidl has removed foods containing hemp from its stores in Germany, Ireland and the Netherlands amid concerns that the products contain excessive levels of THC
CBD beverages continue to be a popular niche sub-category for producers, with brands still experimenting and bringing out new variations. Some significant regulatory concerns remain for the mid/long-term. Neither the US, UK or EU has explicitly permitted CBD to be used as an ingredient for a beverage or any other ingestible product. And there is growing concern that – given » Continue Reading.
Two-star Michelin expertise is coming to the US CBD sector with the advent of a new CBD beverage with flavours developed by British chef Michael Caines
Cult favourite Jones Soda will enter the US cannabis beverage market, while an Oklahoma firm’s new beverage launch looks well positioned to capitalise on any move to a recreational market in the state
CBD-infused drinks company Trip is making its way into the US after it raised $5m (£3.6m) in a Series A funding round last month
Tim Phillips, CBD-Intel’s managing director, recently presented at CBD Live during VOXPO – Virtual Online Vape & CBD Expo on 28th April 2021. In addition to an overview of the impact of Covid-19 on the retail environment, he provided a comparative analysis of the current Novel Food legislation in the UK and the US, as well as discussion around how » Continue Reading.
The long-anticipated UK Food Standards Agency (FSA) initial list of products supported by a validated CBD novel food application has been released
It does not look like good news. The only two companies (controlling three brands that contain 23 individually listed products) included in the initial list of validated applications both say they submitted their applications to the FSA in early January. Both also are at least partly based on synthetic CBD ingredients that have successfully navigated EU novel food application initial » Continue Reading.
Industry reaction to the change in UK Food Standards Agency (FSA) novel food submission requirements is mixed, some welcoming it while others say it reveals failings of management and understanding
Companies now only to have submitted an application to the UK Food Standards Agency (FSA) in order for their edible CBD products to stay on the market after 1st April
CBD-infused gin manufacturer Silent Pool remains defiant after drinks industry regulatory body the Portman Group ruled that its Colorado High product was in violation of its code
Molson Coors and Hexo joint-venture Truss has finally released its CBD beverage in the US state of Colorado.
Officials from the European Commission (EC) met with CBD-Intel to discuss the status of novel food applications in light of the ruling in the Kanavape case
More established brands performed worse than their new upstart rivals in the latest report on CBD labelling accuracy
Berta Camps Bisbal, CBD-Intel’s senior legal analyst, presented a comparative analysis of state laws in the US at CBD Live during VOXPO – Virtual Online Vape & CBD Expo on 18th November. She presented an overview of the federal farm bill as well as CBD at the federal level versus state level. You can now watch her presentation to obtain » Continue Reading.
Current lack of success in Canada and unsupportive regulations in the US have not stopped cannabinoid companies from exploring the beverages sector
The Italian Ministry of Health has suspended the recently published decree listing oral administration of CBD as a medicine under Italy’s Narcotics Law
Concerns over traceability, limiting final use and demonstrating safety of final products could make it difficult to grant UK novel food approval to CBD ingredients producers and white label manufacturers
The company of the president of the European Industrial Hemp Association (EIHA) has challenged a ban on the sale of all foods containing CBD
It’s important to remember that all aspects of cannabis and CBD – even federal decriminalisation or legalisation efforts
The apparently unrelated fields of red yeast rice and stem cell research could provide clues as to how the US Food and Drug Administration (FDA) might deal with market regulation of CBD
There are still quite a few unanswered questions regarding the novel food application process under the FSA. Fortunately the requirement of having toxicological data
A decision by the German city of Düsseldorf to prohibit the sale of all foods containing CBD, including in natural extract form, faces a legal challenge from local hemp wholesaler Hempro International
2020 seems an unlikely year for the emergence of any new industry, yet this is exactly what has happened in Hong Kong, where there are now locally produced CBD food and drink products
CBD-Intel managing director, Tim Phillips, discusses the main facts and issues surrounding CBD and Novel Food status in European markets. He presents the key aspects of the delay, the political issues and the impacts released on the European level and the future challenges for the sector.
Molson Coors has made its long awaited entry into the cannabis market through the launch of its Truss brand of cannabis drinks made in partnership with cannabis company Hexo
Do not expect European novel food authorisations before the end of 2022 at the very earliest and do not expect generic authorisations to cover non-applicant products, a new report from CBD-Intel warns
Charlotte’s Web has been denied a US trademark on appeal – a ruling that has serious implications for any company in the CBD sector selling food, drink or dietary supplement products in the US
A German company is still waiting to hear from the authorities two months after launching new CBD products that could be considered food supplements
Canopy, the Canadian cannabinoid company, has continued to commit heavily to BioSteel, a sports nutrition company in which Canopy now owns the majority share.
Canadian cannabinoid firm Canopy Growth has signed a multi-year deal with NFL quarterback Patrick Mahomes as part of its advance into the sports nutrition market
The opinion (which is not yet set by the EC but appears to be the way the organisation is thinking) is based on a literal reading of the 1961 UN Narcotics Convention.
Authorities have been very tight lipped about the details of the proposed regulations and little is known beyond the title of the document.
Current indications are that the EC is leaning heavily towards the idea that CBD does indeed count as a narcotic under the 1961 Un Convention.
Current indications are that the EC is leaning heavily towards the idea that CBD does indeed count as a narcotic under the 1961 Un Convention.
A TV advertising campaign has significantly boosted sales for a CBD drinks company and it hopes a new listing in a high-end chain of UK supermarkets will consolidate those gains
Although opponents of the ban had their positive result overthrown by the Seventh Circuit Court of Appeals, the decision is not as bad as a headline might suggest.
Enforcement activity against food, drink and dietary supplement products placed on the market containing CBD continues despite the inability of companies to proceed with novel food applications due to the EC’s questions over whether CBD constitutes a narcotic under the 1961 UN Single Convention on Narcotics.
Several major developments have all happened at the same time for novel foods. Perhaps most importantly, one of the European Commission’s departments – the Directorate-General for Health and Food Safety – has said it is holding sending any further non-synthetic CBD applications to the European Food Safety Authority for evaluation until it has determined whether CBD technically falls under the definition of a narcotic according to the 1961 UN Single Convention on Narcotic Drugs.
A new consortium project from the EIHA will put four separate novel food applications in to European and UK authorities after performing the necessary toxicological and safety studies
The UK Food Standards Agency (FSA) has provided further guidance on when a CBD product would need to have a separate or new novel food authorisation
Progress on novel food authorisations for non-synthetic cannabinoids will be paused until European regulators decide whether extracts from hemp flowers constitute a drug under narcotics laws, CBD-Intel has learned
A new line of sparkling CBD drinks is to be launched in the Colorado market in what may be an indication of how high-profile companies approach the CBD market during its continued period of uncertainty
The US state of Virginia has passed a bill to legalise CBD in foods. It expressly permits hemp extracts as food ingredients, as long as they don’t contain more than 0.3% THC
Continued investment and a number of minor launches suggest a CBD beverage from one of the major drinks players in North America may not be far off
German authorities and a major European hemp association have disagreed on the implications of correspondence regarding the novel status of hemp extracts
Scotland has not followed the rest of the UK in setting a deadline for novel food applications, while the Republic of Ireland has adopted an even more conservative approach, stating that unauthorised novel foods should not be on the market at all
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
